Digoxin versus bisoprolol for left atrium reservoir function modulation in atrial fibrillation: A randomized controlled trial.

MLA

Bouchahda, N., et al. “Digoxin versus Bisoprolol for Left Atrium Reservoir Function Modulation in Atrial Fibrillation: A Randomized Controlled Trial.” Archives of Cardiovascular Diseases, vol. 117, no. 1, Jan. 2024, p. S68. EBSCOhost, https://doi.org/10.1016/j.acvd.2023.10.120.

APA

Bouchahda, N., Bader, M., Kallala, M. Y., Messaoud, M. B., Hassine, M., & Gamra, H. (2024). Digoxin versus bisoprolol for left atrium reservoir function modulation in atrial fibrillation: A randomized controlled trial. Archives of Cardiovascular Diseases, 117(1), S68. https://doi.org/10.1016/j.acvd.2023.10.120

Chicago

Bouchahda, N., M. Bader, M.Y. Kallala, M. Ben Messaoud, M. Hassine, and H. Gamra. 2024. “Digoxin versus Bisoprolol for Left Atrium Reservoir Function Modulation in Atrial Fibrillation: A Randomized Controlled Trial.” Archives of Cardiovascular Diseases 117 (1): S68. doi:10.1016/j.acvd.2023.10.120.